What is Soleil Surgical?
Founded in 2014 by Dr. Julio Calderin, Soleil Surgical has established itself as a specialized provider of vascular and podiatric medical services. The practice distinguishes itself through a comprehensive suite of offerings, including outpatient invasive vascular lab procedures and advanced podiatric care. By integrating cutting-edge surgical techniques with a patient-centric, bilingual service model, the company has cultivated a reputation for high-quality, personalized medical intervention. Its market position is defined by a commitment to improving patient outcomes through specialized, accessible care, effectively bridging the gap between complex surgical requirements and community-based medical delivery.
How much funding has Soleil Surgical raised?
Soleil Surgical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Soleil Surgical
PPP
Public-Private Partnership
What's next for Soleil Surgical?
The recent capital injection is expected to catalyze the next phase of growth for Soleil Surgical, likely focusing on the expansion of its outpatient vascular lab infrastructure and the adoption of next-generation surgical technologies. As the firm transitions through this late-stage funding cycle, the strategic priority will shift toward scaling operational efficiencies and broadening its geographic reach. By leveraging this financial support, Soleil Surgical aims to solidify its competitive advantage in the vascular care market, ensuring that its specialized service model remains scalable while maintaining the high standards of clinical excellence that have defined its growth since inception.
See full Soleil Surgical company page
